From Discovery to Delivery
in Rare Disease Research
Ultragentix works with pharmaceutical companies, biotech firms, and research institutions to progress rare disease treatments from initial concept through to manufacturing. We manage the research, the data, and the production, allowing you to focus on the science.
Specialists in Rare Disease Development
Rare diseases demand a different approach. Smaller patient populations, complex regulatory pathways, and highly specialised processes mean there’s no room for generic solutions.
Ultragentix is a UK-based contract research and manufacturing partner dedicated to supporting the full lifecycle of rare disease therapeutics. We provide preclinical research, bioanalytical testing, and specialist manufacturing — all delivered with the precision and confidentiality these projects require.
Our clients include pharmaceutical companies, biotechnology start-ups, universities, and government research bodies across the UK and Europe.
Professional Services
Preclinical Studies
Careful, structured research to establish safety and potential efficacy prior to clinical trials.
Bioanalytical Testing
Assay development, pharmacokinetics, and biomarker analysis for complex or small-scale studies.
Small Molecule Production
Flexible, low-volume manufacture for high-value compounds.
Biologics Manufacturing
Precision production of proteins, antibodies, and vaccines.
Gene & Cell Therapy
Development and small-batch manufacture for advanced therapies.
Specialized Formulation Development
Creating stable, patient-ready formulations tailored to rare disease requirements.
Why Work With Us
We keep things straightforward. Most of our work involves smaller, technically demanding projects where attention to detail makes all the difference.